(TAK) - Analyzing Takeda Pharmaceutical's Short Interest
Portfolio Pulse from Benzinga Insights
Takeda Pharmaceutical's (NYSE:TAK) short interest has decreased by 7.14% since the last report, with 8.23 million shares sold short, representing 0.26% of available shares. The average time to cover these short positions is 5.12 days. A decrease in short interest can indicate a more bullish sentiment towards the stock. Takeda has a lower short interest compared to its peer group average of 3.36%.
December 07, 2023 | 7:00 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Takeda Pharmaceutical's short interest has decreased, which may suggest a more bullish sentiment among investors and could potentially lead to a short-term increase in stock price.
A decrease in short interest typically indicates that investors are less bearish on a stock, which can lead to a short-term increase in its price. However, the article also cautions that this does not necessarily mean the stock will rise in the near term. The confidence level is not at the maximum because the relationship between short interest and stock price is not always direct and can be influenced by various other factors.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100